Investor Advisory Board

Mark Booth
Chief Commercial Officer
Orexigen Therapeutics

Mark Colella
Principal
5AM Ventures

Chris Ehrlich
General Partner  
Interwest Partners

Steve Elms
Managing Partner
Aisling Capital

David Flores
President & CEO
BioCentury

Marc-Henri Galletti
Managing Director
Longitude Capital

Winton Gibbons
Sr VP, Business Development
Nanosphere, Inc.

Arthur Holden
Chairman and CEO, Pharmaceutical Biomedical Research Consortium, Ltd.
iSAEC Consortium

Scott Minick
CEO, ARCH Venture Partners
BIND Bioscience

Evan Norton
Director, Venture Investments
Abbott Ventures

Norbert Riedel, Ph.D.
Corporate Vice President and Chief Scientific Officer
Baxter Healthcare Corporation

Paul Sagan
President and CEO
Akamai Technologies

Sona Wang
Managing Director
Ceres Venture Fund

Dan Watkins
Managing Director
DFJ Mercury